GlassScriptPhysician profile
Michael L Blumenfeld
NPI 1538108345
$7,432.32
in general payments reported to CMS, 2019-2025
11 companies · $90.92 in 2025
The $90.92 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $324 · 2020: $532 · 2021: $1,126 · 2022: $156 · 2023: $2,667 · 2024: $2,536 · 2025: $90.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,900 · Food and Beverage: $966 · Travel and Lodging: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,900.00 |
| Food and Beverage | $966.10 |
| Travel and Lodging | $428.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Samsung Hme America, INC. | $5,378.23 | 2021-2024 | |
| Gynesonics, INC. | $1,053.27 | 2020-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Medtronic, INC. | $193.29 | 2024 | |
| Sage Therapeutics, LLC | $159.96 | 2024 | |
| Carestream Health, INC. | $140.00 | 2019 | |
| Hologic Sales and Service, LLC | $122.30 | 2024 | Acessa Provu System |
| Minerva Surgical, INC | $110.66 | 2024 | |
| Coopersurgical, INC. | $100.00 | 2019 | |
| Biogen, INC. | $90.92 | 2025 | Zurzuvae |
| Abbvie INC. | $47.88 | 2019 | |
| Olympus America INC. | $35.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Blumenfeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.